
NNVC Valuation
NanoViricides Inc
- Overview
- Forecast
- Valuation
- Earnings
NNVC Relative Valuation
NNVC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NNVC is overvalued; if below, it's undervalued.
Historical Valuation
NanoViricides Inc (NNVC) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.69. The fair price of NanoViricides Inc (NNVC) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price:1.53
Fair
-2.63
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
NanoViricides Inc. (NNVC) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -4.39. The thresholds are as follows: Strongly Undervalued below -28.79, Undervalued between -28.79 and -16.59, Fairly Valued between 7.82 and -16.59, Overvalued between 7.82 and 20.02, and Strongly Overvalued above 20.02. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-2.16
EV/EBIT
NanoViricides Inc. (NNVC) has a current EV/EBIT of -2.16. The 5-year average EV/EBIT is -1.42. The thresholds are as follows: Strongly Undervalued below -3.25, Undervalued between -3.25 and -2.34, Fairly Valued between -0.50 and -2.34, Overvalued between -0.50 and 0.42, and Strongly Overvalued above 0.42. The current Forward EV/EBIT of -2.16 falls within the Historic Trend Line -Fairly Valued range.
0.00
PS
NanoViricides Inc. (NNVC) has a current PS of 0.00. The 5-year average PS is 0.35. The thresholds are as follows: Strongly Undervalued below -1.76, Undervalued between -1.76 and -0.70, Fairly Valued between 1.41 and -0.70, Overvalued between 1.41 and 2.47, and Strongly Overvalued above 2.47. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-2.67
P/OCF
NanoViricides Inc. (NNVC) has a current P/OCF of -2.67. The 5-year average P/OCF is -3.12. The thresholds are as follows: Strongly Undervalued below -7.17, Undervalued between -7.17 and -5.15, Fairly Valued between -1.09 and -5.15, Overvalued between -1.09 and 0.93, and Strongly Overvalued above 0.93. The current Forward P/OCF of -2.67 falls within the Historic Trend Line -Fairly Valued range.
-2.77
P/FCF
NanoViricides Inc. (NNVC) has a current P/FCF of -2.77. The 5-year average P/FCF is -2.83. The thresholds are as follows: Strongly Undervalued below -6.90, Undervalued between -6.90 and -4.86, Fairly Valued between -0.80 and -4.86, Overvalued between -0.80 and 1.24, and Strongly Overvalued above 1.24. The current Forward P/FCF of -2.77 falls within the Historic Trend Line -Fairly Valued range.
NanoViricides Inc (NNVC) has a current Price-to-Book (P/B) ratio of 2.73. Compared to its 3-year average P/B ratio of 1.48 , the current P/B ratio is approximately 84.38% higher. Relative to its 5-year average P/B ratio of 1.45, the current P/B ratio is about 87.95% higher. NanoViricides Inc (NNVC) has a Forward Free Cash Flow (FCF) yield of approximately -34.86%. Compared to its 3-year average FCF yield of -38.04%, the current FCF yield is approximately -8.38% lower. Relative to its 5-year average FCF yield of -31.11% , the current FCF yield is about 12.04% lower.
2.73
P/B
Median3y
1.48
Median5y
1.45
-34.86
FCF Yield
Median3y
-38.04
Median5y
-31.11
Competitors Valuation Multiple
The average P/S ratio for NNVC's competitors is 105.55, providing a benchmark for relative valuation. NanoViricides Inc Corp (NNVC) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of NNVC increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of NNVC in the past 1 year is driven by Unknown.
People Also Watch

JL
J-Long Group Ltd
5.900
USD
+1.72%

NEPH
Nephros Inc
4.300
USD
+1.18%

EQS
EQUUS Total Return Inc
1.950
USD
+4.22%

ABVE
Above Food Ingredients Inc
1.850
USD
+1.65%

EDTK
Skillful Craftsman Education Technology Ltd
1.102
USD
+2.04%

GLBZ
Glen Burnie Bancorp
3.960
USD
-0.98%

BTAI
BioXcel Therapeutics Inc
5.670
USD
+3.47%

MLGO
MicroAlgo Inc
8.880
USD
-3.58%
FAQ

Is NanoViricides Inc (NNVC) currently overvalued or undervalued?
NanoViricides Inc (NNVC) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.69. The fair price of NanoViricides Inc (NNVC) is between NaN to NaN according to relative valuation methord.

What is NanoViricides Inc (NNVC) fair value?

How does NNVC's valuation metrics compare to the industry average?

What is the current P/B ratio for NanoViricides Inc (NNVC) as of Aug 19 2025?

What is the current FCF Yield for NanoViricides Inc (NNVC) as of Aug 19 2025?

What is the current Forward P/E ratio for NanoViricides Inc (NNVC) as of Aug 19 2025?
